Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, June 28, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Robert Burns Upgraded (BDTX) to Strong Buy and Held Target at $11 on, Jun 28th, 2023
Robert Burns of HC Wainwright & Co., Upgraded "Black Diamond Therapeutics, Inc." (BDTX) to Strong Buy and Held Target at $11 on, Jun 28th, 2023.
Robert has made no other calls on BDTX in the last 4 months.
There are 2 other peers that have a rating on BDTX. Out of the 2 peers that are also analyzing BDTX, 1 agrees with Robert's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Bradley Canino of "Stifel" Reiterated at Hold and Held Target at $2 on, Tuesday, June 27th, 2023
This is the rating of the analyst that currently disagrees with Robert
- Robert Driscoll of "Wedbush" Upgraded from Hold to Buy and Increased Target to $10 on, Tuesday, June 27th, 2023
